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Abstract
Polyethylene glycol (PEG; 2000 MW, 30% by volume) has been shown to mechanically repair
damaged cellular membranes and reduce secondary axotomy after traumatic brain and spinal cord
injury (TBI and SCI respectively). This repair is achieved following spontaneous reassembly of cell
membranes made possible by the action of targeted hydrophilic polymers which first seal the
compromised portion of the plasmalemma, and secondarily, allow the lipidic core of the
compromised membranes to resolve into each other. Here we compared PEG-treated to
untreated rats using a computer-managed open-field behavioral test subsequent to a standardized
brain injury. Animals were evaluated after a 2-, 4-, and 6-hour delay in treatment after TBI. Treated
animals receive a single subcutaneous injection of PEG. When treated within 2 hours of the injury,
injured PEG-treated rats showed statistically significant improvement in their exploratory behavior
recorded in the activity box when compared to untreated but brain-injured controls. A delay of 4
hours reduced this level of achievement, but a statistically significant improvement due to PEG
injection was still clearly evident in most outcome measures compared at the various evaluation
times. A further delay of 2 more hours, however, eradicated the beneficial effects of PEG injection
as revealed using this behavioral assessment. Thus, there appears to be a critical window of time in
which PEG administration after TBI can provide neuroprotection resulting in an enhanced
functional recovery. As is often seen in clinically applied acute treatments for trauma, the earlier
the intervention can be applied, the better the outcome.
Background
Traumatic brain injury (TBI) is a pernicious event that
destroys many lives. Currently, there are no effective phar-
macological treatments for TBI [1]. Treatments once
thought promising such as the use of corticosteriods have
been determined not to have any neuroprotective quali-
ties [2,3].
PEG has been used subsequent to a standardized TBI in
the rat to reduce cellular damage in brain in various
regions, particularly the white matter of the corpus callo-
sum [4]. Additionally, immunohistochemical staining for
β-Amyloid Precursor Protein, a protein that aggregates in
the axon terminal associated with progressive secondary
axotomy, has been significantly reduced by PEG treatment
after injury [5]. The salutary effects of PEG have likewise
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been seen in the injured spinal cord. The mechanical
interaction of the polymer with only damaged mem-
branes leads to rapid (minutes to hours) improvements in
physiological function, permanent repair of the mem-
brane damage, inhibition of free radical production, and
reduction in the size of progressive cavitation [6-8]. These
actions result in an improved behavioral recovery after
laboratory spinal cord injury (SCI) in guinea pigs and rats,
and in clinical cases of paraplegia in dogs [9].
PEG's membrane sealing and reassembly properties were
originally utilized for vesicle fusion and hybridoma for-
mation [10,9,11]. PEG molecular weights < 4 kD are suf-
ficient to produce cell and axon fusion [12,7], recovery of
conduction in white matter tracts after crush injury [13],
and a reduction in the destruction of axons after spinal
cord crush injury [6,14].
The studies describing the neuroprotective properties of
PEG after brain injury persuaded us to test the effect of
PEG injection on rat behavior after TBI. In the rat, the
same Impact Acceleration injury model as used in the
present investigations produced significant behavioral
impairment [15,1]. Brain-injured animals are impaired in
"open-field" evaluations, the "rotorod" behavioral evalu-
ation, and on the beam walk [16,15]. Open-field explora-
tory behavior is the most ideal preliminary test to apply to
injured animals because this evaluation does not require
"blinding" of the investigator, as this person is not
involved with the taking, or generating of the data. Fur-
thermore, the natural exploratory behavior of the rat pro-
vides the baseline function which also does not require
training but does require cognitive, motivational, and
motor performance capabilities of the study animals.
Methods
Animals
All rats studied were 400–450 gram, adult, Sprague-Daw-
ley rats (Hilltop Lab Animal Inc. Indianapolis, IN, USA).
They were fed (Purina Rat Chow #5001) and allowed
water ad libidum. The animals were housed in a climate-
controlled facility with a 12:12 hour light:dark cycle. All
animal procedures were submitted and approved by the
Purdue University Animal Care and Use Committee, with
strict attention to university, state, and federal guidelines
for the use of animals in research.
Surgical Procedures
Rats were anesthetized with 4% isoflurane in 99% oxygen
(Vetamac, Inc., Rossville, IN, USA, VAD compact anes-
thetic machine with vaporizer) in a laboratory-fabricated
gas chamber. They were intubated endotracheally (Intra-
medic polyethylene tubing, I.D. 1.57 mm, O.D. 2.08 mm,
Fisher Scientific, Hampton, NH, USA) and ventilated with
1.5–2.5% isoflurane in 99% oxygen on a Harvard Appara-
tus small animal ventilator (Holliston, MA, USA). Body
temperature was maintained with a Harvard Apparatus
homeothermic blanket control unit. A midline scalp inci-
sion was performed, and the periosteum removed to
expose the skull. A metal disk, 10 mm in diameter, 3 mm
thick, was firmly attached with Loctite super glue gel and
dental acrylic (Henry Schein, Melville, NY, USA) to the
skull between the lambda and bregma sutures. A 450-
gram brass weight was dropped from a height of two
meters onto the disc to induce a severe impact/accelera-
tion injury using this injury model [4,5,17]. All anesthe-
tized animals received a 0.075 mg/kg intra-muscular
injection of Buprenex and were weaned off the ventilator
within an hour of injury.
General conduct of the study
After laboratory induced TBI using the Marmarou model
[4,5,17] a delay in PEG administration of 2, 4, and 6
hours was tested. (A pilot experiment where PEG injection
was used within the first 15 minutes of the head injury
will be mentioned only briefly, and complete data is not
given).
Nineteen animals of the total of 47 animals used in stud-
ies of the 2–6 hour delay were eliminated from the study
due to death, skull fracture, or euthanization due to pro-
gressive medical problems, an outcome due to using the
most severe form of impact. Of the balance, five rats
underwent a "sham injury" procedure. These received the
same procedures as the injured groups, however the
weight was allowed to drop two to three inches from the
subject's head. These will be described in the text as "sham
injured" or "uninjured" animals. Six "control" rats
received a subcutaneous injection of sterile saline, while
the experimental groups all received subcutaneous injec-
tions of PEG at three time point post injury: six animals at
2 hours, and 8 animals each after a 4-hour, and 6-hour
delay in PEG administration. After behavioral testing, ani-
mals were sacrificed with an overdose of sodium pento-
barbital.
Open-field testing
We direct the interested reader to significant details of the
"activity chamber" construction, the acquisition, manage-
ment, and validation of data in Koob et al 2006. A 30-
minute period of behavioral evaluation in the activity box
was used in these investigations. After experimental TBI, a
subcutaneous injection of PEG was given at 2, 4, and 6
hours later. Behavioral evaluations were made at 24
hours, 4 days, and 7 days post-injury.
Animals were placed in a 100 cm × 100 cm × 20 cm Plex-
iglas activity chamber in a darkened room (the rat's natu-
ral exploratory is most elevated during nocturnal
periods). Inserted at equidistant points around the perim-Journal of Biological Engineering 2008, 2:9 http://www.jbioleng.org/content/2/1/9
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eter of the box, 4.5 cm off the base, four infrared beams in
the X and Y-axis provided data as to the subject's location
at any given point (Fig 1). The smallest sector that the rat
can cross is thus 20 cm × 20 cm. Movements inside the 20
× 20 cm region could be important, however this spacing
was chosen to allow an entire animal to fit inside. In this
initial investigation, we were interested in the rat's ability
to walk (while exploring) after TBI, as the injury is detri-
mental to motor and cognitive behavior, but especially
motor behavior in this injury model [15].
Software designed especially for use with the activity box
interpreted the generated series of data points to deter-
mine the animal's location in space and time over the
course of the experiment (for details and to obtain soft-
ware see [18]).
Coordinates of the rat's position in space over time can be
converted using a spreadsheet (Microsoft Excel, Microsoft,
Seattle, WA, USA) for statistical measurements and the
generation of 2- and 3-dimensional graphs (Fig 2 and 3).
Here, four outcome measures were derived from these
data;:percentage of the area explored, distance traveled,
average speed while exploring, and the percent time spent
exploring.
1. Distance traveled
The distance each subject traveled over the course of data
collection was determined by placing the raw data coordi-
nates of the rat's position into a spreadsheet where each
beam on each axis is assigned an integer, 1–4;X1 and Y1 are
the previous coordinates and X2 and Y2 are the following
coordinates. The equation d  =  √ [(X1-X2)2 + (Y1-Y2)2]
determines distance traveled at each 200 msec interval of
time. Knowing that the distance between each beam is 20
cm, the resulting sum of distance traveled for all time
points over the course of the session is multiplied by 0.2
to give a distance in meters.
2. Average rat speed (m/sec)
Average speed was calculated by aforementioned distance
measurement in meters over the time of the session in sec-
onds.
3. Percent time exploring
In-house developed computer software collected the rat's
coordinates at 200–250 msec intervals, computed the
total number of coordinate pairs recorded and number of
changes in coordinates throughout the exploration ses-
sion. Positional coordinate changes indicate movement,
thus the number of coordinate changes divided by the
total data points recorded equaled the percentage of time
spent exploring. As used here, "Percent Time Exploring"
reflects not simply exploratory behavior but how quickly
and actively the rat moves through the activity box.
4. Percent Area Explored
To determine the amount of area explored, the coordi-
nates of the rat's position were placed into a spreadsheet
file and graphed. If at any given point in time a beam was
broken in the X or Y-axis, the rat's position could be deter-
mined. If beams were not broken, the subject's position
could be determined based on the last beam broken and
next beam broken. Therefore, the position of the rat in
space and time was either determined to be in front of a
beam or between two beams, therefore lending a clear
nine point by nine point grid of potentially explored loca-
tion points. Percent area explored was calculated from this
81 point-location grid.
Results
Overview
An "immediate" intravenous injection of PEG (a proof of
concept pilot study: injection within 15 min of injury; Fig
2, 3; complete data not shown) and the two-hour and 4-
hour delay in subcutaneous injection produced similar
recoveries of behavioral performance in the activity box.
"Open field" evaluation using the activity chamber Figure 1
"Open field" evaluation using the activity chamber. In 
the graphic, infrared beams are rendered as red, and these 
four beams for each axis are equidistant (20 cm) apart 
around the perimeter of the chamber (though in the drawing 
only two are shown in each axis for simplicity). The box is 
100 × 100 × 20 cm. The beams are 4.5 cm high relative to 
the bottom of the chamber. The rat is placed in the middle of 
the chamber at the beginning of the test and usually allowed 
to explore the area for 30 minutes. Food was placed over 
the center of the box on top of a grid screen (not shown). A 
totalizer/counter registered the number of beams broken 
during the period of study. A computer with laboratory 
designed software (see Koob and Cirillo, 2006 for details and 
procurement) registered which individual beam was broken 
to determine where the rat was in space and time.Journal of Biological Engineering 2008, 2:9 http://www.jbioleng.org/content/2/1/9
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After a 2-hour delay in PEG injection, response to the sub-
cutaneous injection of the polymer occurred in 3 of the 4
outcome measures, statistically significantly improved
over controls. Though a trend towards significance was
observed in measurement of the "percentage area
explored", at this sample size it did not reach significance.
Rat open field exploration: 2-D representation Figure 2
Rat open field exploration: 2-D representation. A 2-D representation of rat open field movements as plotted from the 
pilot experiments. One hour (3600 seconds) in the box was used here for demonstration purposes but not in continuing stud-
ies. The x and y axis (1–4) corresponded to the beams crossing the chamber. Using novel computer management of this data 
(see methods), the rat's place in space and time was determined. In A), an uninjured animal explores much of the area over the 
course of an hour. B) A sham injured animal also explores most of the area. In C), an injured untreated animal only explores 
one corner of the box. And in D) an injured PEG-treated animal covers much more area compared to C.Journal of Biological Engineering 2008, 2:9 http://www.jbioleng.org/content/2/1/9
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There was no evidence of enhanced performance when
the delay of PEG injection was extended to 6 hours.
The Delayed Application of PEG
Total distance traveled
When the total distance traveled was compared at all time
points after treatment, the 2-hour delay group was signif-
icantly improved (P ≤ 0.01). A trend towards improve-
ment, but statistically insignificant, was noted at the end
of the first day post-injury following the 4-hour delayed
injection. By 4 days post-injury however, this trend in
improvement had become statistically significant (P ≤
0.05; Figure 4). While the trend towards significance in
the 4-hour delay group was still apparent at 7 days post-
injury, it did not reach significance at this time.
Rat open field movement: 3D representation Figure 3
Rat open field movement: 3D representation. The same data from the previous figure are replotted as a three-dimen-
sional graph(3D); z-axis in seconds (3600 sec). The x and y axis (1–4) correspond to the beams crossing the chamber. In A), an 
uninjured animal explores virtually the entire space. InB) a sham injured animal also explores much of the entire chamber. In 
C), an injured untreated animal does not move much and prefers to sit, stationary (vertical lines), thus exploring little. In D), an 
injured PEG-treated animal explores significantly more space than an injured untreated animal as revealed by these 3-D graphs.Journal of Biological Engineering 2008, 2:9 http://www.jbioleng.org/content/2/1/9
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Rats that received a 6-hour delayed injection performed
worse than even controls in all measurements described
here and below, though this difference was not statisti-
cally significant with the exception of data obtained on
day 4. There was also an increase in the distance traveled
and average speed (see below) after a 2-hour injection of
PEG relative to uninjured animals. The absence of an error
bar indicates an SEM that cannot be distinguished from
the mean in the bar graph.
Average speed attained while exploring
There was a modest trend for improvement in the average
speed attained after PEG injection compared to injured
yet untreated animals. This increase only reached signifi-
cance, however, for PEG-injected animals when adminis-
tered at 2 hours (day 1 and 7), and for the 4-hour delayed
injection at day 4 (Figure 5). Similar to above, the 2-hour
delay in PEG injection led to an apparent increase in
speed compared to untreated animals while further delay
in treatment did not reveal this gain in performance.
Percentage of the time in the activity box spent exploring
Delaying PEG administration by 2 hours produced a sta-
tistically significant increase in the percent time spent
exploring compared to injured yet untreated animals on
day 1 (for the 2-hour group); day 4 (for the 4 hour group)
and at day 7 for both the 2- and 4-hour delayed injection
(Fig 6; P ≤ 0.05). There was no improvement in perform-
ance observed after a 6 hour delay in PEG administration.
Percent area explored
Though there was a weak trend in improvement associ-
ated with the 2- and 4-hour delayed administration of
PEG, none of these improvements were statistically
improved relative to Control rats (Fig 7). It is also likely
that in this outcome measure, a spontaneous and progres-
sive recovery in untreated animals also negatively
impacted these data reaching significance. Overall, it is
important to note that the behavioral improvements
recorded did not disappear with longer times of observa-
tion (out to one week for all studies).
Distance traveled Figure 4
Distance traveled. The mean total distance traveled by rats for their time in the activity chamber. Note the marked decline 
in distance traveled occurring in response to TBI. The improvement produced by the 2-hour delay administration of PEG was 
statistically significant at 1 day, 4 days, and 1 week post-injury (P ≤ 0.05). The 4-hour delay improvement reached significance at 
4 days but showed only a trend towards significance by 1 week postinjury. The 6 hour delayed administration of PEG elimi-
nated any trend towards recovery. Note that in this caseand for all subsequent figures, the precipitous loss in performance 
produced by TBI was statistically significant. Brackets and asterisks are not used to denote this fact in order to simplify reading 
of the graph.Journal of Biological Engineering 2008, 2:9 http://www.jbioleng.org/content/2/1/9
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Discussion
These data suggest that a delay in PEG administration of 2
to 4 hours after TBI does little to diminish its neuroprotec-
tive capability. A delay of 6 hours between injury and
treatment on the other hand eliminates this protective
capability as assayed by the open field test. Moreover, in
nearly all evaluations, the 6-hour delay appeared to
worsen the animal's outcome from TBI when compared to
untreated animals. Though this observation was not sta-
tistically significant in any but one of the comparisons,
the trend is undeniable. In these latter comparisons, there
was no reverse trend observed at any time point for any
PEG injected animal. We emphasize that this interpreta-
tion should not be extended to other behavioral examina-
tions without investigation, though it confirms the
generally held notion that a delay of many hours in treat-
ing acute CNS injury reduces or nullifies the benefits of
the therapy. For example, a delay of 8 hours or more in the
administration of Methylprednisilone eliminates its neu-
roprotective effect in treating acute spinal cord injury. PEG
injections at a therapeutic dose have been given to both
uninjured rats and to dogs [19]. In some cases, the reaction
appears to produce a mild lethargy or increased "nervous-
ness" (we note the increase in activity after the 2-hour
injections in some outcome measures, see Figs. 4 and 5).
However, the degree to which this might impact behavior
after Brain or Spinal Cord Injury is extremely difficult to
assess and thus we have emphasized only the response to
PEG injections relative to controls in injured animals.
Applying "Occam's Razor," we conclude that it was the 6-
hour long delay alone that was responsible for the lack of
behavioral recovery from TBI.
Injections similar to those used here are correlated to a sig-
nificant sparing of brain parenchyma, and a sealing of
neuronal membranes when PEG was administered in the
acute phase of the injury [4]. Sealing of both neurons and
axons in response to PEG was assayed by the uptake of
extracellular markers such as Horseradish peroxidase
(HRP) and Ethylene Bromide that gain entrance to the
cytoplasm only through the collapse of neuronal mem-
brane properties[4]. We also evaluated the presence of β-
Amyloid Precursor Protein in injured axons as a marker
for secondary axotomy [18]. In all cases, significant spar-
ing and rescue of nerves and their processes occurred in
response to acute injection of the polymer.
Considering the two dominant forms of CNS Neurotrauma
These results stand in contrast to our published findings
in SCI. In SCI, a similar program of development was
Average speed attained Figure 5
Average speed attained. Similar to the data in Figure 4, a striking increase in speed was achieved by the 2-hour delayed PEG 
administration at 24 hours and 1 week post-injury (P ≤ 0.01); and by the 4-hour delayed PEG administration at day 4 post-
injury. The 4-hour delay improved this outcome measure at 7 days post-injury, but the increase was not statistically significant. 
The 6-hour delay failed to produce any improvement. Note that these data were especially tightly grouped, and SEMs were not 
drawn onto the bar graph as they were too close to the mean to be easily discerned.Journal of Biological Engineering 2008, 2:9 http://www.jbioleng.org/content/2/1/9
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used; initially even an immediate and topical PEG admin-
istration to the exposed spinal lesion was employed
[7,13]. Later the administration type evolved to subcuta-
neously administered PEG [20], though IV was still
favored by clinicians in a veterinary clinical trial adminis-
tering PEG to paraplegic dogs [19]. In the guinea pig SCI
model, PEG could be withheld for up to 8 hours without
a diminution of its potency and, in the aforementioned
clinical cases, up to 72 hours [19].
It is both instructive and convenient to consider the ana-
tomical basis for the behavioral deficit following TBI and
SCI, as they are indeed significantly different, providing
some insight into the difference in response to polymer
injection in these two regions of the CNS. Most impor-
tantly, white matter is particularly resistant to many of the
factors associated with secondary injury processes in the
CNS such as oxygen and glucose deprivation [21]. The
behavioral deficits that result from spinal cord injury are
nearly all based on the physiological discontinuity after
damage to the long tracts of white matter. It is useful to
consider the catastrophic behavioral loss after spinal cord
injury as an electrophysiologically based outcome where
the failure in nerve impulse conduction between brain
and body is responsible for the vast majority of functional
deficits. Said another way, after SCI, damage to gray mat-
ter plays a minor role in the loss of function [9].
In contrast, neurons are not at all resistant to oxygen and
glucose deprivation, ischemic conditions, and are particu-
larly susceptible to early necrosis after insult compared to
white matter. In traumatic head injury, the loss of neurons
themselves (in addition to the loss in white matter con-
duction) plays a very substantial role in the resultant cat-
astrophic behavioral loss, both motor/sensory, as well as
cognitive. Therefore, there is relatively little time post-
injury to affect a rescue of cerebral neurons of the brain
when compared to the rescue of comparatively resilient
white matter subsequent to SCI. Slowly degenerating
white matter within the spinal cord is thus available for
longer times after injury to respond to membrane – seal-
ing agents like PEG or Poloxamer – 188. There may be
other relevant factors such as changes in the vasculature
with time and the sealing of the blood brain barrier at ~5
to 8 hours post-injury in the brain that may also be asso-
ciated with the loss of PEG effectiveness after cerebral
injury. We believe that the extended window in time for
the effective use of PEG in SCI is related to these facts.
Conclusion
These data suggest that PEG may be clinically useful to vic-
tims of TBI if delivered as rapidly as possible after injury.
Presently we are beginning a veterinary clinical study of
the effect of acute PEG administration in naturally injured
canines suffering head injury [19]. It is possible in both
The Percentage of time spent exploring the activity chamber Figure 6
The Percentage of time spent exploring the activity chamber. As seen in previous outcome measures, the 2-hour 
delay showed a significant improvement over untreated animals at 1 day and 7 days post-injury (P ≤ 0.01), though not reaching 
significance at 4 days post-injury. The 4-hour delay also showed a trend in improvement at these time points but reached sig-
nificance at only the 4 days post-injury evaluation (P ≤ 0.05). A 6-hour delay in the administration of PEG failed to produce any 
improvement in this outcome measure.Journal of Biological Engineering 2008, 2:9 http://www.jbioleng.org/content/2/1/9
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dogs and humans to deliver PEG (dissolved in IV fluids)
at, or close to, the accident site. Furthermore, particularly
in urban areas, human patients may be admitted to emer-
gency care within 4 hours of their accident. Still it is wise
to ponder a possible precipitous decline in PEG's benefi-
cial capabilities as an intervention in TBI and to consider
ways to reduce this decline.
Since 1999, we have explored various concentrations and
MWs of PEG in pursuing its use as a neuroprotective-seal-
ing agent. Our choices in MW began with the older litera-
ture of PEG-mediated cell fusion dating to the 1970s
[22,7,10] and practical concerns governing the viscosity
and fluid load of injection of a PEG solution into animals.
Importantly, the lower the molecular weight of PEG, the
more toxic might be the byproducts of degradation in the
body (the monomer is, of course, extremely toxic). Higher
molecular weights of PEG (over 1000 daltons) pose no
safety risk whatsoever and have been safely used in medi-
cine for over 30 years [23,10]. Thus we see little room for
variation from the MW and concentrations used in this
series of studies. On the other hand, application via IV or
another route might possibly extend the therapeutic win-
dow for use in TBI; however, we doubt this to be the case.
PEG preferentially targets the damaged tissues of both spi-
nal cord and brain while not labeling healthy or undam-
aged tissue [4,20]. When decorated PEG was used to
determine the relative efficacy of intraveneous, intraperi-
toneal, or subcutaneous injection, all three types of
administration similarly marked damaged spinal cord (as
significantly as a topical application of PEG directly to the
lesion) [20]. Thus there is little reason to believe we can
improve the therapeutic benefits of PEG by changing the
conventional means of administration or making differ-
ent choices in the polymer's MW or concentration used
for injection.
In our view, it is more likely that a combination treatment
may offer the best hope of a significant clinical therapy.
For example, acute administration of aldehyde scavengers
[24] may prolong neuron survival in the brain long
enough for PEG to exert an effect in tandem. Drugs meant
to modify the deleterious effects of ischemia and reper-
fusion injury, unsuccessful on their own, might find
renewed utility when combined with polymer infusion.
We are currently considering these alternates as new plans
of study.
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